Dr. Robert Damoiseaux’s main interests are at the interface of chemistry, biology and engineering and include the development of novel assay technology platforms, High Throughput Screening, High Content Screening and nanotechnology. After having earned a Ph.D. degree at the University of Lausanne (Switzerland) where he worked on directed molecular evolution of antibodies he joined the Novartis Institute for Functional Genomics (GNF) in La Jolla, CA in 2001. Since 2004 he is the Director of the Molecular Shared Screening Resources (MSSR) at the California NanoSystems Institute of UCLA and Professor in the Department of Molecular and Medical Pharmacology. He has authored over 100 papers and patents spanning many different disease indications such as oncology, infectious diseases and immunology using many different screening platforms. He is also the current chair of the UC Drug Discovery Consortium which is bringing researchers from across the entire UC together to develop new drugs in collaboration with Industry.